Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans

Autor: Rie Kakehashi, Takeshi Mori, Daisuke Ishibashi, Honami Kojima, Takahiro Uchida, Toshihiro Nagao, Ikuo Kawasaki, Taku Yamashita, Minoru Ozeki, Miyako Yoshida, Rio Uno, Mai Hazekawa, Jun-ichi Nishikawa, Yoshiro Hatanaka
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
antimicrobial peptide
QH301-705.5
medicine.medical_treatment
Peptide
macromolecular substances
medicine.disease_cause
Catalysis
Cathelicidin
Microbiology
Inorganic Chemistry
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
transmission electron microscopy
medicine
Physical and Theoretical Chemistry
Biology (General)
Candida albicans
Molecular Biology
Escherichia coli
QD1-999
Spectroscopy
chemistry.chemical_classification
mutant peptide
biology
Chemistry
conjugation with poly (lactic-co-glycolic) acid
Organic Chemistry
technology
industry
and agriculture

General Medicine
Antimicrobial
biology.organism_classification
Computer Science Applications
PLGA
030104 developmental biology
Staphylococcus aureus
030220 oncology & carcinogenesis
scanning electron microscopy
Conjugate
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 10
International Journal of Molecular Sciences, Vol 22, Iss 5097, p 5097 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms22105097
Popis: Various peptides and their derivatives have been reported to exhibit antimicrobial activities. Although these activities have been examined against microorganisms, novel methods have recently emerged for conjugation of the biomaterials to improve their activities. Here, we prepared CKR12-PLGA, in which CKR12 (a mutated fragment of human cathelicidin peptide, LL-37) was conjugated with poly (lactic-co-glycolic) acid (PLGA), and compared the antimicrobial and antifungal activities of the conjugated peptide with those of FK13 (a small fragment of LL-37) and CKR12 alone. The prepared CKR12-PLGA was characterized by dynamic light scattering and measurement of the zeta potential, critical micellar concentration, and antimicrobial activities of the fragments and conjugate. Although CKR12 showed higher antibacterial activities than FK13 against Staphylococcus aureus and Escherichia coli, the antifungal activity of CKR12 was lower than that of FK13. CKR12-PLGA showed higher antibacterial activities against S. aureus and E. coli and higher antifungal activity against Candida albicans compared to those of FK13. Additionally, CKR12-PLGA showed no hemolytic activity in erythrocytes, and scanning and transmission electron microscopy suggested that CKR12-PLGA killed and disrupted the surface structure of microbial cells. Conjugation of antimicrobial peptide fragment analogues was a successful approach for obtaining increased microbial activity with minimized cytotoxicity.
Databáze: OpenAIRE